| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 5e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |